• Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics
• /
• v.30 no.1
• /
• pp.12-14
• /
• 2019

Functional dysphonia (FD) is a disease entity which includes various voice disorders in the absence of structural or neurologic laryngeal pathology. Muscle tension dysphonia (MTD), psychogenic dysphonia are representative FD with completely different pathogenesis. Therefore there is no standard treatment modality for FD, the first step of treatment of FD is differentiating patient's voice symptoms from other organic voice disorders and other functional voice problems. MTD is a functional voice disorder caused by hyperfunction of intrinsic and extrinsic laryngeal musculature. Symptoms include increased vocal effort, roughness, fatigue and odynophonia. First line for MTD is indirect or direct voice therapy. Unfortunately, many patients with MTD improve with voice therapy alone. For these patients, various modalities tried; lidocaine application, surgical excision of the false vocal folds, and botulinum toxin injection, etc. Botulinum toxin injections are widely used in the field of otolaryngology, especially for spasmodic dysphonia. However, its use in FD or MTD has only been described in few case reports. The aim of this lecture is to evaluate the feasibility of botulinum toxin injection for FD, especially MTD.

• Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics
• /
• v.28 no.2
• /
• pp.100-105
• /
• 2017

Background and Objectives : Adductor type spasmodic dysphonia (ADSD) is neurogenic disorder and focal laryngeal dystonia, while muscle tension dysphonia (MTD) is caused by functional voice disorder. Both ADSD and MTD may be associated with excessive supraglottic contraction and compensation, resulting in a strained voice quality with spastic voice breaks. The aim of this study was to determine the utility of spectrogram analysis in the differentiation of ADSD from MTD. Materials and Methods : From 2015 through 2017, 17 patients of ADSD and 20 of MTD, underwent acoustic recording and phonatory function studies, were enrolled. Jitter (frequency perturbation), Shimmer (amplitude perturbation) were obtained using MDVP (Multi-dimensional Voice Program) and GRBAS scale was used for perceptual evaluation. The two speech therapist evaluated a wide band (11,250 Hz) spectrogram by blind test using 4 scales (0-3 point) for four spectral findings, abrupt voice breaks, irregular wide spaced vertical striations, well defined formants and high frequency spectral noise. Results : Jitter, Shimmer and GRBAS were not found different between two groups with no significant correlation (p>0.05). Abrupt voice breaks and irregular wide spaced vertical striations of ADSD were significantly higher than those of MTD with strong correlation (p<0.01). High frequency spectral noise of MTD were higher than those of ADSD with strong correlation (p<0.01). Well defined formants were not found different between two groups. Conclusion : The wide band spectrograms provided visual perceptual information can differentiate ADSD from MTD. Spectrogram analysis is a useful diagnostic tool for differentiating ADSD from MTD where perceptual analysis and clinical evaluation alone are insufficient.

• Proceedings of the KSLP Conference
• /
• 2009.03a
• /
• pp.19-19
• /
• 2009

• Proceedings of the KOR-BRONCHOESO Conference
• /
• 1991.06a
• /
• pp.31-31
• /
• 1991

후두격막은 1822년 Fleichman이 호흡곤란과 발성장애를 야기한 례를 최초로 보고하였으며 선천성으로나 후천성으로 발생할 수 있다. 선천성후두격막은 태생 10주경의 후두발생장애로 발생한다고 알려져 있으며 성문부위에서 가장 많이 발견되며 후천성후두격막은 감염, 외상, 수술 및 방사선조사 후 발생한다. 저자들은 최근 1례의 선천성후두격막과 4례의 후천성후두격막환자를 치험하였기에 문헌고찰과 함께 보고하는 바이다.

• The Journal of the Acoustical Society of Korea
• /
• v.42 no.4
• /
• pp.298-303
• /
• 2023

This study aimed to investigate the clinical utility of voiced sentence tasks for voice evaluation. To this end, we analyzed the correlation between perturbation-based acoustic measurements [jitter percent (jitter), shimmer percent (shimmer), Noise to Harmonic Ratio (NHR)] using sustained vowel phonation, and cepstrum-based acoustic measurements [Cepstral Peak Prominence (CPP), Low/High spectral ratio (L/H ratio)] using voiced sentences. As a result of analyzing data collected from 65 patients with voice disorders, there was a significant correlation between the CPP and jitter (r = -.624, p = .000), shimmer (r = -.530, p = .000), NHR (r = -.469, p = .000).This suggests that the cepstrum measurement of voiced sentences can be used as an alternative to the analysis limitations of the pathological voice such as not possible perturbation-based acoustic measurement, and result difference according to the analysis section.

• Proceedings of the KSLP Conference
• /
• 2012.03a
• /
• pp.22-22
• /
• 2012

• Proceedings of the KSLP Conference
• /
• 2008.03a
• /
• pp.15-15
• /
• 2008

• Proceedings of the KSLP Conference
• /
• 2015.03a
• /
• pp.20-20
• /
• 2015

• Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics
• /
• v.23 no.2
• /
• pp.99-103
• /
• 2012

Spasmodic dysphonia is a chronic, focal, movement-induced, action-specific dystonia of the laryngeal musculature during speech. It can have a profound effect on quality of life, severely limiting people's communication, especially via telephone and in noisy backgrounds. Spasmodic dysphonia (SD) is usually of the adductor type characterized by glottic contractions causing tightness and voice breaks with forced-strangled voice, but it may also be abductor type or, much less commonly, mixed. Treatment options for adductor spasmodic dysphonia (ADSD) include voice therapy, surgical procedures, and botulinum toxin injections (Botox). The use of Botox injected into the laryngeal muscles remains the "gold standard" treatment for reducing the vocal symptoms of ADSD and Botox induces a temporary paresis of the laryngeal muscles and provides short-term relief of symptoms. Repeated injections of the laryngeal muscles, generally every 3-4 months, are required for continuous relief of symptoms. Improvement in vocal function has been reported after use of Botox injections, though a completely normal voice is rarely achieved. In this hospital, 1,030 patients have been enrolled for Botox injection therapy so far (May, 2012). In this review article, I'd like to present my personal experience of management of spasmodic dysphonia mainly by Botox injection.

• Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics
• /
• v.30 no.2
• /
• pp.132-135
• /
• 2019

Spasmodic dysphonia is a focal laryngeal dystonia that results in involuntary spasms during speech. The etiology of spasmodic dysphonia is not yet defined, but it is presumed to be a neurological abnormality of central nervous system motor function. The treatment of choice for spasmodic dysphonia is botulinum toxin injection directly at the laryngeal muscles. However botulinum toxin injection requires repeated procedures. Many different kinds of surgical treatments have been introduced but the recurrence rate is still high. So we performed myomectomy with LASER and neurectomy with specially designed electrical surgical knife which can cut recurrent laryngeal nerve branch selectively with its noble curved section. We report a case of a 43-year-old male patient with spasmodic dysphonia treated by thyroarytenoid myoneurectomy.